LexDanaLexDanabeta
Inventor

Pia M. Challita-Eid

Inventor
Encino, CA, US

Overview

112→
Patents
2005–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 112 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides22%
A61KPreparations for medical, dental or toiletry purposes20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
G01NInvestigating or analysing materials by determining their chemical or physical properties10%
Y02ATechnologies for adaptation to climate change9%
C12NMicroorganisms or enzymes7%
A01KAnimal husbandry6%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms4%
Y10TTechnical subjects covered by former us classification3%
C07HSugars1%
PatentTitleYear
10,597,463Antibodies and molecules derived therefrom that bind to STEAP-1 proteins20209,617,346'Antibodies and molecules derived therefrom that bind to STEAP-1 proteins'20179,029,516'Antibodies and molecules derived therefrom that bind to STEAP-1 proteins'20159,023,605'Antibodies and molecules derived therefrom that bind to STEAP-1 proteins'20158,951,744'Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers'20158,945,570'Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers'20158,853,364'Prostate stem cell antigen (PSCA) variants and subsequences thereof'20148,846,043'Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer'20148,779,111'Antibodies to tumor associated proteins'20148,647,826'Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer'20148,604,169'Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer'20138,562,989'Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer'20138,524,872'Nucleic acids and corresponding proteins entitled 158P3D2 useful in treatment and detection of cancer'20138,497,351'Nucleic acid and corresponding protein entitled 162P1E6 useful in treatment and detection of cancer'20138,460,881'Nucleic acids and corresponding proteins entitled 254P1D6B useful in treatment and detection of cancer'20138,426,571'Nucleic acids and corresponding proteins entitled 202P5A5 useful in treatment and detection of cancer'20138,350,009'Antibodies and related molecules that bind to 161P2F10B proteins'20138,298,776'Antibodies to tumor associated proteins'20128,278,424'Antibodies that bind to PSCA proteins for diagnosis of cancer'20128,236,310'Antibodies and related molecules that bind to 161P2F10B proteins'20128,236,510'Protein showing enhanced expression in cancer cells'20128,212,017'Nucleic acids and corresponding proteins entitled 158P3D2 useful in treatment and detection of cancer'20128,206,932'Antibodies and related molecules that bind to PSCA proteins'20128,188,228'Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer'20128,173,132'Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancer'20128,173,381'Nucleic acid and corresponding protein entitled 85P1B3 useful in treatment and detection of cancer'20128,168,187'Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer'20128,124,741'Antibodies to tumor associated proteins'20128,057,996'Nucleic acids and corresponding proteins entitled 202P5A5 useful in treatment and detection of cancer'20118,039,000'Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer'20118,039,597'Antibodies and related molecules that bind to 24P4C12 proteins'20118,039,603'Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer'20118,012,937'Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer'20118,013,135'Antibodies and molecules derived therefrom that bind to STEAP-1 proteins'20118,013,128'Antibodies and related molecules that bind to PSCA proteins'20118,013,126'84P2A9: a prostate and testis specific protein highly expressed in prostate cancer'20118,008,442'Antibodies and molecules derived therefrom that bind to STEAP-1 proteins'20118,003,100'Antibodies that bind to 238P1B2'20117,982,004'Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer'20117,977,062'Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer'20117,968,090'Nucleic acids and corresponding proteins entitled 191P4D12(b) useful in treatment and detection of cancer'20117,968,099'Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer'20117,960,527'Nucleic acid and corresponding protein entitled 151P3D4 useful in treatment and detection of cancer'20117,951,375'Methods of inducing an immune response'20117,947,276'Antibodies and molecules derived therefrom that bind to STEAP-1 proteins'20117,939,503'Reduction of cell-cell communication in prostate cancer using STEAP-1 siRNA'20117,935,491'Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer'20117,928,196'Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer'20117,927,597'Methods to inhibit cell growth'20117,923,543'Nucleic acid and corresponding protein entitled 162P1E6 useful in treatment and detection of cancer'20117,892,548'121P1F1: a tissue specific protein highly expressed in various cancers'20117,884,179'Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer'20117,879,570'Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer'20117,858,750'Antibodies to tumor associated proteins'20107,842,458'Nucleic acids and corresponding proteins entitled 58P1D12 useful in treatment and detection of cancer'20107,834,156'125P5C8: tissue specific protein highly expressed in various cancers'20107,811,565'Antibodies and related molecules that bind to 161P2F10B proteins'20107,811,575'Nucleic acids and corresponding proteins entitled 158P3D2 useful in treatment and detection of cancer'20107,795,391'Protein showing enhanced expression in cancer cells'20107,759,474'Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer'20107,749,746'Nucleic acid encoding 238P1B2 useful in detecting cancer'20107,736,654'Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers'20107,732,584'Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer'20107,700,749'Nucleic acid and corresponding protein entitled 205P1B5 useful in treatment and detection of cancer'20107,696,336'Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer'20107,667,018'Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer'20107,667,015'Nucleic acid and corresponding protein entitled 151P3D4 useful in treatment and detection of cancer'20107,659,377'Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer'20107,655,234'Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer'20107,641,905'Methods of inducing an immune response'20107,642,342'Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer'20107,638,270'Nucleic acids and corresponding proteins entitled 254P1D6B useful in treatment and detection of cancer'20097,628,989'Methods of inducing an immune response'20097,622,564'Prostate stem cell antigen (PSCA) variants and subsequences thereof'20097,622,569'Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer'20097,615,379'Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer'20097,612,172'Nucleic acids and corresponding proteins entitled 282P1G3 useful in treatment and detection of cancer'20097,601,825'Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer'20097,595,379'Antibodies and related molecules that bind to PSCA proteins'20097,592,149'Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer'20097,585,505'Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer'20097,582,448'84P2A9: a prostate and testis specific protein highly expressed in prostate cancer'20097,563,444'Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancer'20097,553,814'238P1B2 protein'20097,541,442'Antibodies and related molecules that bind to PSCA proteins'20097,534,417'103P2D6: tissue specific protein highly expressed in various cancers'20097,510,840'Method of inhibiting growth or survival of a cell by providing an anti-108P5H8 antibody'20097,510,855'84P2A9: a prostate and testis specific protein highly expressed in prostate cancer'20097,501,502'Nucleic acid and corresponding protein entitled 85P1B3 useful in treatment and detection of cancer'20097,494,646'Antibodies and molecules derived therefrom that bind to STEAP-1 proteins'20097,488,479'Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer'20097,459,539'Antibody that binds zinc transporter protein 108P5H8'20087,449,548'Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer'20087,427,399'Antibodies and related molecules that bind to 161P2F10B proteins'20087,405,290'Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer'20087,361,338'Methods to inhibit growth of prostate cancer cells'20087,358,353'Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers'20087,309,585'121P1F1: a tissue specific protein highly expressed in various cancers'20077,279,556'Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer'20077,271,240'125P5C8: a tissue specific protein highly expressed in various cancers'20077,250,498'Nucleic acids and corresponding proteins entitled 273P4B7 useful in treatment and detection of cancer'20077,244,827'Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer'20077,226,594'Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer'20077,217,799'Antibodies that recognize the 85P1B3 protein useful in treatment and detection of cancer'20077,208,280'Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer'20077,199,220'103P2D6: tissue specific protein highly expressed in various cancers'20077,172,898'103P2D6: tissue specific protein highly expressed in various cancers'20077,135,549'Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer'20067,115,727'Nucleic acids and corresponding proteins entitled 282P1G3 useful in treatment and detection of cancer'20067,067,130'Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer'20066,924,358'121P1F1: a tissue specific protein highly expressed in various cancers'20056,863,892'Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers'2005

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2005–2020Patents assigned to AGENSYS INC (112)· patent assignee history
2005–2020Based in Encino, CA, US· patent location history
2011–2015Patents assigned to CHALLITA-EID PIA M (24)· patent assignee history
2011–2015Patents assigned to JAKOBOVITS AYA (24)· patent assignee history
2011–2015Patents assigned to RAITANO ARTHUR B (24)· patent assignee history
2011–2014Patents assigned to GE WANGMAO (18)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
AGENSYS INC1122005–2020
CHALLITA-EID PIA Mself242011–2015
JAKOBOVITS AYA242011–2015
RAITANO ARTHUR B242011–2015
GE WANGMAO182011–2014
Locations
LocationPatentsSpan
Encino, California, US1122005–2020